The condition affects approximately 15% of the global adult population.
However, treatment has remained elusive, with those afflicted left to find their own ad hoc mitigation solutions.
Neuromod, a medtech startup from Ireland, is looking to change that.
The company has just received 30 million infundingto further commercialise its tinnitus treatment equipment, Lenire.
It’s free, every week, in your inbox.
Simultaneously, Bluetooth headphones deliver customised sound stimuli to the auditory nerve.
Furthermore, the decrease in discomfort persisted over a post-therapeutic study phase which lasted up to 12 months.
Panakes Partners managing director Alessio Beverina will join Neuromods board.
Existing investor Fountain Healthcare Partners also participated in the expansion of the Series B funding.
Initial patient treatment in the US will begin this month.
Tinnitus treatment is one of the largest unmet clinical needs in the world.
Story byLinnea Ahlgren
Linnea is the senior editor at TNW, having joined in April 2023.
Dabbles in gaming and fitness wearables.
But first, coffee.
